Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) Operating Income: ₺2,678 Mil (TTM As of Mar. 2026)


IST:GENIL Gen Ilac Ve Saglik Urunleri Sanayi ve Ticaret AS IST:GENIL
86 GF Score
Price ₺9.10
GF Value ₺8.17
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Gen Ilac Veglik Urunlerinayi ve Ticaret AS Operating Income?

Gen Ilac Veglik Urunlerinayi ve Ticaret AS IST:GENIL +1.34% 86 Operating Income is ₺2,678 Mil as of Mar. 2026. GuruFocus rates IST:GENIL with a GF Score™ of 86/100 and a GF Value™ of ₺8.17 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Operating Income for the three months ended in Mar. 2026 was ₺1,126 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 was ₺2,678 Mil.

Operating Margin % is calculated as Operating Income divided by its Revenue. Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Operating Income for the three months ended in Mar. 2026 was ₺1,126 Mil. Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Revenue for the three months ended in Mar. 2026 was ₺6,624 Mil. Therefore, Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Operating Margin % for the quarter that ended in Mar. 2026 was 17.00%.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's 5-Year average Growth Rate for Operating Margin % was -0.90% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Gen Ilac Veglik Urunlerinayi ve Ticaret AS's annualized ROC % for the quarter that ended in Mar. 2026 was 20.70%. Gen Ilac Veglik Urunlerinayi ve Ticaret AS's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 33.41%.


Gen Ilac Veglik Urunlerinayi ve Ticaret AS  (IST:GENIL) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=4504.008 * ( 1 - 27.81% )/( (14101.231 + 17306.264)/ 2 )
=3251.4433752/15703.7475
=20.70 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=19450.351 - 3257.33 - ( 2135.979 - max(0, 7773.769 - 9865.559+2135.979))
=14101.231

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=22309.55 - 3632.382 - ( 1370.904 - max(0, 9074.379 - 12024.496+1370.904))
=17306.264

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=3042.172/( ( (5875.505 + max(1887.026, 0)) + (6103.024 + max(4347.606, 0)) )/ 2 )
=3042.172/( ( 7762.531 + 10450.63 )/ 2 )
=3042.172/9106.5805
=33.41 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(2083.554 + 2342.293 + 2339.498) - (3257.33 + 0 + 1620.989)
=1887.026

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(4344.275 + 2597.849 + 1962.635) - (3632.382 + 0 + 924.771)
=4347.606

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. Operating Income is also linked to Operating Margin %:

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Operating Margin % for the quarter that ended in Mar. 2026 is calculated as:

Operating Margin %=Operating Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=1126.002/6624.046
=17.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.


Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Gen Ilac Veglik Urunlerinayi ve Ticaret AS Operating Income Related Terms


Gen Ilac Veglik Urunlerinayi ve Ticaret AS Operating Income Historical Data

* Premium members only.

The historical data trend for Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Operating Income Chart

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Operating Income
Get a 7-Day Free Trial 272.34 1,255.87 898.99 1,535.31 2,470.12

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 954.53 571.24 638.71 341.94 1,126.00
IST:GENIL
86GF Score
Gen Ilac Ve Saglik Urunleri Sanayi ve Ticaret AS IST:GENIL
Operating Income is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₺2,678 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Income →
What does a Operating Income of ₺2,678 Mil mean?
Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) has a Operating Income of ₺2,678 Mil as of Mar. 2026. Operating Income equals sales less all operating expenses. It is linked to EBIT. View historical data on Gen Ilac Veglik Urunlerinayi ve Ticaret AS and its competitors.
Is Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Operating Income too high?
Gen Ilac Veglik Urunlerinayi ve Ticaret AS's current Operating Income is ₺2,678 Mil. Overall, Gen Ilac Veglik Urunlerinayi ve Ticaret AS has a GF Score™ of 86/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Operating Income compare to ZTS and UTHR?
Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Operating Income of ₺2,678 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Income for a Drug Manufacturers company?
A good Operating Income depends on the Drug Manufacturers industry context. However, Operating Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Income mean?
A high Operating Income can signal that a stock is expensive relative to its fundamentals. Operating Income equals sales less all operating expenses. It is linked to EBIT. View historical data on Gen Ilac Veglik Urunlerinayi ve Ticaret AS and its competitors. Gen Ilac Veglik Urunlerinayi ve Ticaret AS's current Operating Income is ₺2,678 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gen Ilac Veglik Urunlerinayi ve Ticaret AS stock overvalued right now?
Based on GuruFocus' analysis, Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) is currently considered Modestly Overvalued. The stock's GF Value™ is ₺8.17, compared to a current price of ₺9.10 — trading 11.4% above its estimated fair value. The current Operating Income is ₺2,678 Mil. Gen Ilac Veglik Urunlerinayi ve Ticaret AS's overall GF Score™ is 86/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Income calculated?
Operating Income is calculated from a company's financial statements. For Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL), the current Operating Income is ₺2,678 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) Overvalued in 2026?

Based on GuruFocus' analysis, Gen Ilac Veglik Urunlerinayi ve Ticaret AS stock appears to be overvalued. The current stock price of ₺9.10 is trading 11.4% above its estimated GF Value™ of ₺8.17. GuruFocus considers Gen Ilac Veglik Urunlerinayi ve Ticaret AS to be Modestly Overvalued.

Key valuation signals for IST:GENIL:

  • Operating Income: ₺2,678 Mil
  • GF Value™: ₺8.17 vs. price of ₺9.10 (11.4% above fair value)
  • GF Score™: 86/100 with 5 warning signs

No single metric tells the full story. See the IST:GENIL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Gen Ilac Veglik Urunlerinayi ve Ticaret AS Business Description

Address Mustafa Kemal Mahallesi 2119.Sk. No:3, Cankaya, Ankara, TUR, 06520
Gen Ilac Ve Saglik Urunleri Sanayi ve Ticaret AS is a specialty pharmaceuticals company in Turkey. Its locally manufactured products include Cajex, Contra-K, Epamor, Genkort, Ilopera, among others, while imported products include AvonexPEN, Plegridy, Tecfidera, Regen-D among others.
86GF Score

Get the complete analysis for IST:GENIL

Operating Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₺9.10
Price
₺8.17
GF Value